Rifamycins are a class of antibiotics that were first discovered in 1957 and are known for
their use in treating tuberculosis (TB). Rifamycins exhibit bactericidal activity against many …

Infections caused by Gram-positive bacteria are a major public health problem due to their
increasing resistance to antibiotics. Staphylococcus and Enterococcus species' resistance …

Staphylococcus aureus biofilm-associated infections are a major public health concern.
Current therapies are hampered by reduced penetration of antibiotics through biofilm and …

Rifampin is a potent antibiotic against staphylococcal implant-associated infections. In the
absence of implants, current data suggest against the use of rifampin combinations. In the …

Rifamycins are widely used for treating mycobacterial and staphylococcal infections. Drug-
drug interactions (DDI) caused by rifampicin (RIF) are a major issue. We used a model …

Introduction The study aims to describe phageome of soil rhizosphere of M. oleifera in terms
of the genes encoding CAZymes and other KEGG enzymes. Methods Genes of the …

Purpose This study was performed to explore the physicochemical and anti-biofilm
properties of rifampin (Rif) and cis-2-decenoic acid (C2DA) co-entrapped in solid lipid …

Background Owing to patient intolerance or drug interactions, alternative agents to rifampin
are needed for management of staphylococcal periprosthetic joint infection. In the current …

Drug-resistant Gram-positive bacterial infections are still a substantial burden on the public
health system, with two bacteria (Staphylococcus aureus and Streptococcus pneumoniae) …

These days, the eradication of bacterial infections is more difficult due to the mechanism of
resistance that bacteria have developed towards traditional antibiotics. One of the medical …